North America Epilepsy Drugs Market Size & Outlook
The epilepsy drugs market in North America is expected to reach a projected revenue of US$ 5,934.5 million by 2030. A compound annual growth rate of 5.5% is expected of North America epilepsy drugs market from 2025 to 2030.